(S)-(+)-2-氨基-3-环己基-1-丙醇 盐酸盐 | 117160-99-3

• 物质功能分类: 生物化工 - 氨基酸及其衍生物 - 氨基醇类衍生物
• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: (S)-(+)-2-氨基-3-环己基-1-丙醇 盐酸盐
• 中文别名: (S)-(+)-2-氨基-3-环己基-1-丙醇盐酸盐；(S)-(+)-2-氨基-3-环己基-1-丙醇盐酸；S)-(+)-2-氨基-3-环己基-1-丙醇盐
• 英文名称: (S)-3-cyclohexyl-2-aminopropanol hydrochloride
• 英文别名: (S)-2-Amino-3-cyclohexylpropan-1-ol hydrochloride；(2S)-2-amino-3-cyclohexylpropan-1-ol;hydrochloride
• CAS: 117160-99-3
• 化学式: C₉H₁₉NO*ClH
• 分子量: 193.717
• InChiKey: BMHYDTXNZNVADC-FVGYRXGTSA-N

物化性质

• 熔点：
  230 °C (dec.)(lit.)
• 稳定性/保质期：
  如果按照规格使用和储存，则不会分解，没有已知危险反应。请避免与强氧化物接触。

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  46.2
• 氢给体数：
  3
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36
• 危险类别码：
  R36/37/38
• WGK Germany：
  3
• 海关编码：
  2922199090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: (S)-(+)-2-Amino-3-cyclohexyl-1-propanol HCl
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Ingredient name: (S)-(+)-2-Amino-3-cyclohexyl-1-propanol HCl
CAS number: 117160-99-3

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
Eye contact:
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
No data
Boiling point:
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C9H19NO.ClH
Molecular weight: 193.7

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (S)-(+)-2-氨基-3-环己基-1-丙醇 盐酸盐 在 sodium hydride 、 三乙胺 、 N,N-二异丙基乙胺 、 三氟乙酸 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 二氯甲烷 、 水 为溶剂， 反应 20.25h， 生成 2(S)-3-cyclohexyl-1-tert-butylthio-2-propylamine
  参考文献：
  名称：

  发现了一系列具有强细胞活性的含环己基乙胺的蛋白质法呢基转移酶抑制剂。

  摘要：

  基于Sebti-Hamilton型拟肽法呢基转移酶（FTase）抑制剂FTI-276（1）的仲苄基胺文库的合成导致6被鉴定为有效的酶抑制剂（IC（50）为8 nM），缺乏有问题的硫醇残基，这是迄今为止报道的许多更重要的FTase抑制剂的常见主题。先前已经公开了在一般描述2的FTase抑制剂中添加邻甲苯基取代对整个细胞中的FTase抑制和Ras异戊二烯基化抑制均具有有益的作用。这两个观察结果的结合使我们合成了7种有效的FTase抑制剂，其在体外抑制FTase的IC（50）为0.16 nM，而在抑制全细胞Ras异戊二烯化时的EC（50）为190 nM。通过经典药物化学对7的修饰导致发现了一系列有效的FTase抑制剂，最终鉴定出25个，其IC（50）为0.20 nM，EC（50）为4.4 nM。在人胰腺癌裸鼠异种移植模型（MiaPaCa细胞）中进行的体内测试显示，口服25剂量可显着减弱这种侵袭性肿瘤细胞系的生长。

  DOI：

  10.1021/jm990335v
• 作为产物：
  描述：

  N-叔丁氧羰基-L-苯丙氨酸甲酯 在 sodium tetrahydroborate 、 5% rhodium-on-charcoal 、 氢气 作用下， 以 甲醇 、 水 为溶剂， 60.0 ℃ 、411.6 kPa 条件下， 反应 16.0h， 生成 (S)-(+)-2-氨基-3-环己基-1-丙醇 盐酸盐
  参考文献：
  名称：

  芳香族氨基酸及其衍生物的还原

  摘要：

  苯丙氨酸和苯甘氨酸衍生物的催化还原可以用碳或氧化铝上的铑来实现，从而得到相应的环己基衍生物的良好收率。该过程可以缩放。

  DOI：

  10.1021/op0200773

文献信息

• [EN] RENIN INHIBITORS AND METHOD OF USE THEREOF<br/>[FR] INHIBITEURS DE LA RÉNINE ET PROCÉDÉ D'UTILISATION CORRESPONDANT
  申请人：VITAE PHARMACEUTICALS INC

  公开号：WO2009154766A1

  公开（公告）日：2009-12-23

  Disclosed are aspartic protease inhibitors represented by the following Formula: wherein R1 , R2, R3, R4, R5, R6, R7a, R7b and n are as defined herein, or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the same and methods for treating an aspartic protease mediated disorder using the same.

  以下是由下式表示的天冬氨酸蛋白酶抑制剂：其中R1，R2，R3，R4，R5，R6，R7a，R7b和n如本文所定义，或其药学上可接受的盐，包括相同的药物组成物和使用相同的方法治疗由天冬氨酸蛋白酶介导的疾病。
• Terephthalamide derivatives
  申请人：Dongwha Pharmaceutical Ind. Co., Ltd.

  公开号：US05922871A1

  公开（公告）日：1999-07-13

  The present invention relates to novel terephthalamide derivatives and in particular to novel terephthalamide derivatives of the following formula 1, its pharmaceutically acceptable salts as antiviral agents having remarkable inhibitory actions against the proliferation of various viruses including HIV and HBV, and preparing method thereof ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are the same as defined in the detailed description of the present invention.

  本发明涉及新型对苯二甲酰胺衍生物，特别是涉及以下式1所示的新型对苯二甲酰胺衍生物，其药学上可接受的盐作为抗病毒剂，对包括HIV和HBV在内的多种病毒的增殖具有显著的抑制作用，以及其制备方法 ##STR1## 其中R1、R2和R3的定义与本发明详细说明中的定义相同。
• [EN] PROTEASOME INHIBITOR COMPRISING A SIGNAL-EMITTING MOIETY<br/>[FR] INHIBITEUR DE PROTÉASOME COMPRENANT UNE FRACTION D'ÉMISSION DE SIGNAL
  申请人：TECHNISCHE UNIVERSITÄT MÜNCHEN

  公开号：WO2017032487A1

  公开（公告）日：2017-03-02

  The present invention relates to compounds such as peptides which act as proteasome inhibitors. The compounds are covalently linked with a signal emitting compound or a precursor thereof, via an ester such as a sulfonic ester group for imaging of the inhibition of the proteasome. The compound is for use in the quantification of proteasomal inhibition, diagnosis and/or prevention and/or treatment of autoimmune diseases, cancer, neurodegenerative diseases, viral infections and/or diseases associated with inflammation. The invention further relates to methods to produce the compounds.

  本发明涉及类似肽的化合物，其作为蛋白酶体抑制剂。这些化合物与发射信号化合物或其前体通过酯（例如磺酯基团）共价连接，用于成像蛋白酶体的抑制。该化合物用于定量蛋白酶体抑制、自身免疫疾病、癌症、神经退行性疾病、病毒感染以及与炎症相关的疾病的诊断、预防和/或治疗。该发明还涉及生产这些化合物的方法。
• Probes of the active site of norepinephrine N-methyltransferase: effect of hydrophobic and hydrophilic interactions on side-chain binding of amphetamine and .alpha.-methylbenzylamine
  作者：Gary L. Grunewald、James Monn、Michael F. Rafferty、Ronald T. Borchardt、Polina Krass

  DOI：10.1021/jm00352a031

  日期：1982.10

  ine were prepared and evaluated as inhibitors of norepinephrine N-methyltransferase (NMT). These included several alkyl side chain extended analogues (1-5), as well as the terminally hydroxylated derivatives phenylalanol (6a) and phenylglycinol (7a). None of the alkyl-substituted derivatives displayed appreciable activity as inhibitors; however, the hydroxylated analogues were up to twofold more potent

  制备了一系列的ω-取代的苯丙胺和α-甲基苄胺类似物，并评价为去甲肾上腺素N-甲基转移酶（NMT）的抑制剂。这些包括几种烷基侧链延伸的类似物（1-5），以及末端羟基化的衍生物苯丙醇（6a）和苯甘醇（7a）。没有一种烷基取代的衍生物显示出明显的抑制剂活性。然而，羟基化类似物的效力比母体化合物高两倍。侧链羟基的正贡献表明，先导化合物的末端甲基位于活性位点的亲水区域或氢键官能团附近。
• Microwave-Assisted Ring-Opening of Activated Aziridines with Resin-Bound Amines
  作者：François Crestey、Matthias Witt、Karla Frydenvang、Dan Stærk、Jerzy W. Jaroszewski、Henrik Franzyk

  DOI：10.1021/jo702612u

  日期：2008.5.1

  nosylamide-activated aziridines under microwave irradiation conditions in solid-phase synthesis (SPS). The effects of solvent, temperature, reaction time, and reagent ratio in SPS of partially protected triamines from aziridines and resin-bound diamines were investigated. The methodology was also optimized for the synthesis of novel amino acid derivatives.

  本文描述了在固相合成（SPS）中在微波辐射条件下，由Nosylamide活化的氮丙啶进行亲核开环的第一个研究。研究了溶剂，温度，反应时间和试剂比率对部分保护的三胺与氮丙啶和树脂结合的二胺的SPS的影响。还对该方法进行了优化，以合成新的氨基酸衍生物。